Scotia Capital Inc. Has $67.02 Million Stock Position in Nutrien Ltd. (NYSE:NTR)

Scotia Capital Inc. cut its stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 2.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,500,685 shares of the company's stock after selling 40,374 shares during the quarter. Scotia Capital Inc. owned approximately 0.31% of Nutrien worth $67,018,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Uncommon Cents Investing LLC boosted its position in Nutrien by 2.1% in the fourth quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company's stock valued at $517,000 after buying an additional 235 shares in the last quarter. Rhumbline Advisers raised its stake in shares of Nutrien by 3.5% in the fourth quarter. Rhumbline Advisers now owns 7,398 shares of the company's stock valued at $331,000 after acquiring an additional 247 shares during the last quarter. FFT Wealth Management LLC boosted its holdings in shares of Nutrien by 0.9% in the 4th quarter. FFT Wealth Management LLC now owns 29,732 shares of the company's stock worth $1,330,000 after acquiring an additional 277 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in Nutrien by 23.9% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,804 shares of the company's stock worth $81,000 after acquiring an additional 348 shares during the last quarter. Finally, PFG Investments LLC grew its position in Nutrien by 2.0% during the 4th quarter. PFG Investments LLC now owns 20,097 shares of the company's stock worth $899,000 after acquiring an additional 386 shares during the last quarter. Institutional investors and hedge funds own 63.10% of the company's stock.

Remove Ads

Nutrien Trading Up 1.9 %

NTR traded up $0.99 during mid-day trading on Monday, hitting $52.15. The stock had a trading volume of 1,979,701 shares, compared to its average volume of 2,068,171. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. Nutrien Ltd. has a 1-year low of $43.70 and a 1-year high of $60.87. The stock's fifty day simple moving average is $50.74 and its 200-day simple moving average is $49.13. The firm has a market capitalization of $25.49 billion, a price-to-earnings ratio of 38.07, a price-to-earnings-growth ratio of 1.19 and a beta of 0.77.

Nutrien (NYSE:NTR - Get Free Report) last posted its earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The business had revenue of $5.08 billion during the quarter, compared to analyst estimates of $5.09 billion. As a group, research analysts forecast that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.

Nutrien Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, April 10th. Shareholders of record on Monday, March 31st were issued a dividend of $0.545 per share. The ex-dividend date of this dividend was Monday, March 31st. This represents a $2.18 annualized dividend and a yield of 4.18%. Nutrien's dividend payout ratio (DPR) is currently 159.12%.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Scotiabank boosted their price objective on Nutrien from $60.00 to $62.00 and gave the stock a "sector outperform" rating in a research note on Monday, February 24th. Royal Bank of Canada reiterated an "outperform" rating and set a $60.00 price target on shares of Nutrien in a research report on Monday, February 24th. Piper Sandler raised their price objective on shares of Nutrien from $58.00 to $63.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. Barclays upped their target price on shares of Nutrien from $56.00 to $59.00 and gave the stock an "equal weight" rating in a research report on Wednesday, March 5th. Finally, The Goldman Sachs Group began coverage on shares of Nutrien in a research report on Thursday, March 13th. They issued a "sell" rating and a $53.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Nutrien currently has an average rating of "Moderate Buy" and an average target price of $60.00.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.